Cargando…

High Prevalence of Dyslipidemia in Children and Adolescents: Opportunity for Prevention

Detalles Bibliográficos
Autor principal:	Mangili, Leonardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2020
Materias:	Short Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025315/ https://www.ncbi.nlm.nih.gov/pubmed/32049170 http://dx.doi.org/10.36660/abc.20190761

Ejemplares similares

Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?
por: Tanaka, Ana Cristina Sayuri
Publicado: (2018)

Prevalence of Dyslipidemia and Associated Factors in Obese Children and Adolescents
por: Elmaoğulları, Selin, et al.
Publicado: (2015)

Clinical and diagnostic importance of dyslipidemia in children and adolescents during the coronavirus disease 2019 pandemic
por: Kim, Eun Young
Publicado: (2022)

Early echocardiographic screening for subclinical myocardial dysfunction in children and adolescents with dyslipidemia: why and when?
por: Lee, Hyun Gyung, et al.
Publicado: (2022)

Prevalence of dyslipidemia in Iranian children and adolescents: A systematic review
por: Hovsepian, Silva, et al.
Publicado: (2015)

Injuries among Amish children: opportunities for prevention
por: Strotmeyer, Stephen, et al.
Publicado: (2019)

ERICA: prevalence of dyslipidemia in Brazilian adolescents
por: Faria, José Rocha, et al.
Publicado: (2016)

Dyslipidemia and Cardiovascular Disease: Current Knowledge, Existing Challenges, and New Opportunities for Management Strategies
por: Du, Zhiyong, et al.
Publicado: (2023)

Screening and Management of Dyslipidemia in Children and Adolescents
por: Schefelker, Juliette M., et al.
Publicado: (2022)

Prevalence of Dyslipidemia among School-Age Children and Adolescents in Addis Ababa, Ethiopia
por: Mohammed, Ousman, et al.
Publicado: (2022)

Amlamax™ in the Management of Dyslipidemia in Humans
por: Antony, B., et al.
Publicado: (2008)

Editorial: Secondary Dyslipidemias
por: Elisaf, Moses, et al.
Publicado: (2011)

Dyslipidemia and Breast Cancer
por: Aggarwal, Neelam, et al.
Publicado: (2018)

Endothelial stiffening in dyslipidemia
por: Le Master, Elizabeth, et al.
Publicado: (2019)

New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China()
por: Hu, Da-Yi
Publicado: (2016)

Management of Dyslipidemia in Secondary Prevention of Cardiovascular Disease: The Gap between Theory and Practice
por: Santangelo, Gloria, et al.
Publicado: (2022)

Prevalence of Dyslipidemia in Children with Congenital Heart Disease
por: Fuenmayor, Gabriela, et al.
Publicado: (2013)

The prevalence of hookah smokers among Belarussian children and adolescents
por: Pronina, Tanya, et al.
Publicado: (2023)

Prevalence and factors associated with dyslipidemia among adolescents in Saudi Arabia
por: AlMuhaidib, Shadan, et al.
Publicado: (2022)

Prevalence of dyslipidemia, atherogenic and cardiovascular risk in overweight and obese adolescents
por: de Andrades, Clara dos Santos, et al.
Publicado: (2023)

The Draupadi of dyslipidemia: Familial hypercholesterolemia
por: Kalra, Sanjay, et al.
Publicado: (2016)

No association between subclinical hypothyroidism and dyslipidemia in children and adolescents
por: Habib, Ashkan, et al.
Publicado: (2020)

Dyslipidemia in Children and Adolescents: When and How to Diagnose and Treat?
por: Yoon, Jung Min
Publicado: (2014)

Dyslipidemia is Associated with Unfit and Overweight-Obese Children and Adolescents
por: Reuter, Cézane Priscila, et al.
Publicado: (2016)

Dyslipidemia Diagnosis and Treatment: Risk Stratification in Children and Adolescents
por: Mosca, Sara, et al.
Publicado: (2022)

Lipid Profiles and Prevalence of Dyslipidemia in Eastern Iranian Adolescents, Birjand, 2012
por: Taheri, Fatemeh, et al.
Publicado: (2015)

2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents
por: Lim, Jung Sub, et al.
Publicado: (2020)

2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents
por: Lim, Jung Sub, et al.
Publicado: (2020)

Challenges in the Pharmacologic Management of Obesity and Secondary Dyslipidemia in Children and Adolescents
por: Kennedy, Mary Jayne, et al.
Publicado: (2013)

Role of Complementary and Alternative Medicine in Controlling Dyslipidemia
por: Qidwai, Waris, et al.
Publicado: (2014)

Time to consider an Asian guideline for management of dyslipidemia?
por: Yokote, Koutaro, et al.
Publicado: (2012)

Diets, Foods and Food Components’ Effect on Dyslipidemia
por: Fogacci, Federica, et al.
Publicado: (2021)

The Prevalence of Abdominal Obesity and Metabolic Syndrome in Korean Children and Adolescents
por: Cho, Ja Hyang
Publicado: (2023)

The Prevalence of Dyslipidemia among Jordanians
por: Abujbara, Mousa, et al.
Publicado: (2018)

Prevention of mental disorders: evidence, challenges and opportunities
por: Jacka, Felice N, et al.
Publicado: (2014)

Management of dyslipidemia in children
por: Kalra, Sanjay, et al.
Publicado: (2009)

Phytosterol supplementation in the treatment of dyslipidemia in children and adolescents: a systematic review
por: Mantovani, Luisa Montone, et al.
Publicado: (2020)

Using Body Composition Groups to Identify Children and Adolescents at Risk of Dyslipidemia
por: Ofenheimer, Alina, et al.
Publicado: (2021)

Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities
por: Lin, Pei-Hui, et al.
Publicado: (2020)

Prevalence and Determinants of Overweight and Obesity Among Adolescent School Children of South Karnataka, India
por: Kotian, M Shashidhar, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_oorl945152sqfi9o37on70ae53